475 related articles for article (PubMed ID: 31793175)
1. Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression.
Yang Q; Sun H; Wang X; Yu X; Zhang J; Guo B; Hexige S
J Cell Mol Med; 2020 Jan; 24(2):1179-1188. PubMed ID: 31793175
[TBL] [Abstract][Full Text] [Related]
2. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
3. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma.
Ma L; Wang H; Yao H; Zhu L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Aug; 17(4):327-30. PubMed ID: 23639414
[TBL] [Abstract][Full Text] [Related]
4. A genome-wide association scan of biological processes involved in oral lichen planus and oral squamous cell carcinoma.
Yang Q; Xu B; Sun H; Wang X; Zhang J; Yu X; Ma X
Medicine (Baltimore); 2017 Jun; 96(25):e7012. PubMed ID: 28640079
[TBL] [Abstract][Full Text] [Related]
5. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
6. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD.
Ogmundsdóttir HM; Hilmarsdóttir H; Astvaldsdóttir A; Jóhannsson JH; Holbrook WP
Eur J Oral Sci; 2002 Jun; 110(3):192-8. PubMed ID: 12120703
[TBL] [Abstract][Full Text] [Related]
7. Recurrent chromosomal and epigenetic alterations in oral squamous cell carcinoma and its putative premalignant condition oral lichen planus.
Németh CG; Röcken C; Siebert R; Wiltfang J; Ammerpohl O; Gassling V
PLoS One; 2019; 14(4):e0215055. PubMed ID: 30964915
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of MYC status in oral lichen planus in patients with progression to oral squamous cell carcinoma.
Segura S; Rozas-Muñoz E; Toll A; Martín-Ezquerra G; Masferrer E; Espinet B; Rodriguez M; Baró T; Barranco C; Pujol RM
Br J Dermatol; 2013 Jul; 169(1):106-14. PubMed ID: 23461699
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 expression in oral lichen planus, dysplastic lesions and squamous cell carcinoma.
Jaafari-Ashkavandi Z; Aslani E
Pathol Res Pract; 2017 Jul; 213(7):809-814. PubMed ID: 28554768
[TBL] [Abstract][Full Text] [Related]
10. Association of MAPK and its regulatory miRNAs (603, 4301, 8485, and 4731) with the malignant transformation of oral lichen planus.
Gholizadeh N; Emami Razavi A; Mohammadpour H; Tavakol F; Sheykhbahaei N
Mol Biol Rep; 2020 Feb; 47(2):1223-1232. PubMed ID: 31828562
[TBL] [Abstract][Full Text] [Related]
11. Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus.
Xu Z; Shen Z; Shi L; Sun H; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Oct; 17(5):408-11. PubMed ID: 23707659
[TBL] [Abstract][Full Text] [Related]
12. Update of the cancer-associated molecular mechanisms in oral lichen planus, a disease with possible premalignant nature.
Georgakopoulou EA; Troupis TG; Troupis G; Gorgoulis VG
J BUON; 2011; 16(4):613-6. PubMed ID: 22331711
[TBL] [Abstract][Full Text] [Related]
13. Markers of Oral Lichen Planus Malignant Transformation.
Tampa M; Caruntu C; Mitran M; Mitran C; Sarbu I; Rusu LC; Matei C; Constantin C; Neagu M; Georgescu SR
Dis Markers; 2018; 2018():1959506. PubMed ID: 29682099
[TBL] [Abstract][Full Text] [Related]
14. Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential.
Lončar-Brzak B; Klobučar M; Veliki-Dalić I; Sabol I; Kraljević Pavelić S; Krušlin B; Mravak-Stipetić M
Clin Oral Investig; 2018 Mar; 22(2):1071-1082. PubMed ID: 28779221
[TBL] [Abstract][Full Text] [Related]
15. Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by
Soltaninezhad P; Arab F; Mohtasham N; FakherBaheri M; Kavishahi NN; Aghaee-Bakhtiari SH; Zare-Mahmoodabadi R; Pakfetrat A; Taban KI; Mohajertehran F
Curr Pharm Des; 2024; 30(4):310-322. PubMed ID: 38310566
[TBL] [Abstract][Full Text] [Related]
16. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
[TBL] [Abstract][Full Text] [Related]
17. Role of tumor suppressor protein p16 in patients with oral lichen planus.
Hadzi-Mihailovic M; Stanimirovic D; Pasoski B
J BUON; 2020; 25(2):1193-1198. PubMed ID: 32521925
[TBL] [Abstract][Full Text] [Related]
18. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Potential Risk Factors that contribute to Malignant Transformation of Oral Lichen Planus: A Literature Review.
Agha-Hosseini F; Sheykhbahaei N; SadrZadeh-Afshar MS
J Contemp Dent Pract; 2016 Aug; 17(8):692-701. PubMed ID: 27659090
[TBL] [Abstract][Full Text] [Related]
20. Suitability/unsuitability of cell proliferation as an indicator of malignant potential in oral lichen planus: an immunohistochemical study.
Zargaran M; Jamshidi S; Eshghyar N; Moghimbeigi A
Asian Pac J Cancer Prev; 2013; 14(11):6979-83. PubMed ID: 24377636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
